U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673016) titled 'Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer' on June 09.
Brief Summary: This is a prospective, multicenter observational study designed to collect urine and tumor biospecimens and associated clinical data from patients undergoing evaluation, treatment, or surveillance for urothelial carcinoma.
Study Start Date: Oct. 15, 2019
Study Type: OBSERVATIONAL
Condition:
Bladder Cancer
Urothelial Carcinoma (UC)
Hematuria
Upper Tract Urothelial Cancer
Recruitment Status: RECRUITING
Sponsor: Convergent Genomics, Inc.
Disclaimer: Curated by HT Syndica...